Alphatec Holdings, Inc. (NASDAQ: ATEC) stands out as a compelling player in the healthcare sector, specifically within the dynamic field of medical devices. The company, headquartered in Carlsbad, California, is..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a prominent player in the biotechnology industry, continues to capture investor attention with its innovative therapeutic developments and significant market presence. With a current market..
For investors eyeing the biotechnology sector, CG Oncology, Inc. (NASDAQ: CGON) presents a compelling opportunity. With a market capitalization of $3.22 billion, this Irvine, California-based company specializes in developing innovative..
Alignment Healthcare, Inc. (NASDAQ: ALHC) is carving a distinctive niche in the healthcare industry with its consumer-centric platform designed to cater to the needs of seniors through Medicare Advantage plans...
Viking Therapeutics, Inc. (NASDAQ: VKTX) has emerged as a standout player in the biotechnology sector, capturing the attention of investors with its promising pipeline and significant upside potential. With a..
Amicus Therapeutics, Inc. (NASDAQ: FOLD), a prominent player in the biotechnology sector, has been making waves with its focus on rare diseases. As the company continues to expand its footprint..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to treating rare and orphan diseases. Headquartered in Foster City,..
Metsera, Inc. (NASDAQ: MTSR), a subsidiary of Pfizer Inc., is a clinical-stage biotechnology company that has carved out its niche in the healthcare sector. Based in New York, Metsera focuses..
Investors eyeing the healthcare sector should take note of PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a standout in the medical devices industry that has shown remarkable revenue growth and promising future..
Veracyte, Inc. (VCYT) stands as a notable entity in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $3.39 billion, this California-based company is..
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a U.S.-based biotechnology company, stands as an intriguing prospect in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a..
MoonLake Immunotherapeutics (MLTX) is a burgeoning player in the biotechnology sector, making waves with its innovative approach to treating inflammatory skin and joint diseases. As a clinical-stage company based in..
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is emerging as a compelling player in the biotechnology sector, capturing investor interest with a significant potential upside of 43.92%. The company, headquartered in Watertown,..
LifeStance Health Group, Inc. (NASDAQ: LFST) is an intriguing player in the healthcare sector, specifically within the medical care facilities industry. Founded in 2017 and based in Scottsdale, Arizona, the..
Addus HomeCare Corporation (NASDAQ: ADUS) has positioned itself as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. The company, with a market capitalization of..
Scholar Rock Holding Corporation (NASDAQ: SRRK), a promising player in the biotechnology sector, is catching the attention of investors with its innovative focus on developing treatments for serious diseases. As..
Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices sector, continues to capture investor interest with its innovative suite of hospital technologies. Based in Boston, Massachusetts, Haemonetics has..
ImmunityBio, Inc. (NASDAQ: IBRX) has been making waves in the biotechnology industry with its innovative approach to cancer and infectious disease treatment. With a market capitalization of $2.01 billion, this..
Privia Health Group, Inc. (NASDAQ: PRVA), a key player in the health information services sector, has been catching the eye of investors with its robust growth metrics and a noteworthy..
Arcellx, Inc. (NASDAQ: ACLX) is drawing investor attention with its promising biotechnology endeavors and an impressive potential upside of 72.51%. Specializing in cutting-edge immunotherapies for cancer and other incurable diseases,..
